» Articles » PMID: 22363827

Estimating the Non-monetary Burden of Neurocysticercosis in Mexico

Overview
Date 2012 Feb 25
PMID 22363827
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Neurocysticercosis (NCC) is a major public health problem in many developing countries where health education, sanitation, and meat inspection infrastructure are insufficient. The condition occurs when humans ingest eggs of the pork tapeworm Taenia solium, which then develop into larvae in the central nervous system. Although NCC is endemic in many areas of the world and is associated with considerable socio-economic losses, the burden of NCC remains largely unknown. This study provides the first estimate of disability adjusted life years (DALYs) associated with NCC in Mexico.

Methods: DALYs lost for symptomatic cases of NCC in Mexico were estimated by incorporating morbidity and mortality due to NCC-associated epilepsy, and morbidity due to NCC-associated severe chronic headaches. Latin hypercube sampling methods were employed to sample the distributions of uncertain parameters and to estimate 95% credible regions (95% CRs).

Findings: In Mexico, 144,433 and 98,520 individuals are estimated to suffer from NCC-associated epilepsy and NCC-associated severe chronic headaches, respectively. A total of 25,341 (95% CR: 12,569-46,640) DALYs were estimated to be lost due to these clinical manifestations, with 0.25 (95% CR: 0.12-0.46) DALY lost per 1,000 person-years of which 90% was due to NCC-associated epilepsy.

Conclusion: This is the first estimate of DALYs associated with NCC in Mexico. However, this value is likely to be underestimated since only the clinical manifestations of epilepsy and severe chronic headaches were included. In addition, due to limited country specific data, some parameters used in the analysis were based on systematic reviews of the literature or primary research from other geographic locations. Even with these limitations, our estimates suggest that healthy years of life are being lost due to NCC in Mexico.

Citing Articles

Seroprevalence and Risk Factors for Cysticercosis in Mexican Americans in Starr County, Texas.

Duffey M, OConnell E, Jibowu M, Moron F, Leining L, Tang N Pathogens. 2024; 13(11).

PMID: 39599541 PMC: 11597702. DOI: 10.3390/pathogens13110988.


Transclival endoscopic approach for prepontine cistern neurocysticercosis causing trigeminal neuralgia: illustrative case.

Lines-Aguilar W, Garcia H, Saavedra L, Caucha Y, Heredia D, Romero F J Neurosurg Case Lessons. 2024; 8(13).

PMID: 39312806 PMC: 11418639. DOI: 10.3171/CASE24223.


Current Role of Surgery in the Treatment of Neurocysticercosis.

Hamamoto Filho P, Norcia L, Fleury A, Zanini M Pathogens. 2024; 13(3).

PMID: 38535559 PMC: 10976164. DOI: 10.3390/pathogens13030218.


Global research on cysticercosis and neurocysticercosis: A bibliometric analysis.

Gonzalez-Alcaide G, Sosa N, Shevy L, Belinchon-Romero I, Ramos-Rincon J Front Vet Sci. 2023; 10:1156834.

PMID: 37113561 PMC: 10126342. DOI: 10.3389/fvets.2023.1156834.


Assessing the burden of Taenia solium cysticercosis in Burundi, 2020.

Minani S, Devleesschauwer B, Gasogo A, Ntirandekura J, Gabriel S, Dorny P BMC Infect Dis. 2022; 22(1):851.

PMID: 36376817 PMC: 9661784. DOI: 10.1186/s12879-022-07849-7.


References
1.
Flisser A, Sarti E, Lightowlers M, Schantz P . Neurocysticercosis: regional status, epidemiology, impact and control measures in the Americas. Acta Trop. 2003; 87(1):43-51. DOI: 10.1016/s0001-706x(03)00054-8. View

2.
. Guidelines for epidemiologic studies on epilepsy. Commission on Epidemiology and Prognosis, International League Against Epilepsy. Epilepsia. 1993; 34(4):592-6. DOI: 10.1111/j.1528-1157.1993.tb00433.x. View

3.
Rajshekhar V, Joshi D, Doanh N, De N, Xiaonong Z . Taenia solium taeniosis/cysticercosis in Asia: epidemiology, impact and issues. Acta Trop. 2003; 87(1):53-60. DOI: 10.1016/s0001-706x(03)00055-x. View

4.
Lipton R, Scher A, Steiner T, Bigal M, Kolodner K, Liberman J . Patterns of health care utilization for migraine in England and in the United States. Neurology. 2003; 60(3):441-8. DOI: 10.1212/wnl.60.3.441. View

5.
Burneo J, Tellez-Zenteno J, Wiebe S . Understanding the burden of epilepsy in Latin America: a systematic review of its prevalence and incidence. Epilepsy Res. 2005; 66(1-3):63-74. DOI: 10.1016/j.eplepsyres.2005.07.002. View